title: DPA n-3, DPA n-6 and DHA improve lipoprotein profiles and aortic function in hamsters fed a high cholesterol diet.
abstract: The present study examined the cholesterol-lowering activity of omega-3 docosapentaenoic acid (DPA n-3), omega-6 docosapentaenoic acid (DPA n-6) and docosahexaenoic acid (DHA), and their interaction with gene expression of transporters, receptors and enzymes involved in cholesterol absorption and metabolism as well as their effect on aortic function. Forty hamsters were fed either the control diet containing 0.4% stearic acid or one of the three experimental diets containing 0.4% DPA n-3, 0.4% DPA n-6 and 0.4% DHA. Results showed that supplementation of these three fatty acids reduced plasma total cholesterol (TC) and non high-density-lipoprotein cholesterol (non-HDL-C) by 29-33% and 29-50%, respectively, compared with the control. The reduction in TC and non-HDL-C was accompanied by down-regulation of hepatic SREBP-2 and HMG-CoA reductase. Aorta from DPA n-3 and DHA groups was found to have significantly lesser tension and relax better than that from the control and DPA n-6 hamsters, largely mediated by their inhibition on the gene expression of cycloxygense-2 (COX-2). It was concluded that all three fatty acids were beneficial in improving lipoprotein profile with DPA n-3 and DHA having better effect on aortic function.
authors.affiliation: Department of Biology and Kwong Living Trust Food Safety & Analysis Laboratory, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
authors.forename: Jingnan
authors.initials: J
authors.lastname: Chen
authors.forename: Yue
authors.initials: Y
authors.lastname: Jiang
authors.forename: Yintong
authors.initials: Y
authors.lastname: Liang
authors.forename: Xiaoyu
authors.initials: X
authors.lastname: Tian
authors.forename: Cheng
authors.initials: C
authors.lastname: Peng
authors.forename: Ka Ying
authors.initials: KY
authors.lastname: Ma
authors.forename: Jian
authors.initials: J
authors.lastname: Liu
authors.forename: Yu
authors.initials: Y
authors.lastname: Huang
authors.forename: Zhen-Yu
authors.initials: ZY
authors.lastname: Chen
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects* / Q000503:physiopathology; D001018:Aortic Diseases / Q000097:blood / Q000209:etiology / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control*; D001835:Body Weight / Q000187:drug effects; D002791:Cholesterol, Dietary / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D006224:Cricetinae; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D019587:Dietary Supplements; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005243:Feces / Q000737:chemistry; D005786:Gene Expression Regulation / Q000187:drug effects; D006903:Hydroxymethylglutaryl CoA Reductases / Q000235:genetics / Q000378:metabolism; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008074:Lipoproteins / Q000097:blood*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008647:Mesocricetus; D012333:RNA, Messenger / Q000378:metabolism; D051782:Sterol Regulatory Element Binding Protein 2 / Q000235:genetics / Q000378:metabolism; D014280:Triglycerides / Q000097:blood; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D016861:Cyclooxygenase Inhibitors; D005231:Fatty Acids, Unsaturated; D008074:Lipoproteins; D012333:RNA, Messenger; D051782:Sterol Regulatory Element Binding Protein 2; D014280:Triglycerides; D014665:Vasodilator Agents; D004281:Docosahexaenoic Acids; D006903:Hydroxymethylglutaryl CoA Reductases; D051546:Cyclooxygenase 2; C489691:Ptgs2 protein, rat; C026219:docosapentaenoic acid